12 , ,
This acidic formulation, combined with the acylation modification that extends its half-life, likely contributes to local tissue irritation
Compounding pharmacies make customized medicines for individual patients, and under section 503A of the Food, Drug, and Cosmetic Act, a pharmacy can compound from a bulk substance only if that substance has an official quality monograph, is a component of an FDA-approved drug, or has been formally added to an approved bulks list. BPC-157 qualifies on none of those counts, which is why the FDA placed it in Category 2 of its 503A bulk-substance review in September of 2023
At BHRC, our physicians utilize BPC-157 as part of comprehensive healing protocols for injury recovery, gut health optimization, and tissue regeneration
The site had been marketing BPC-157 as a gut-healing, wound-healing therapy